Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH

Journal of Virology

Volumn 86, Issue 7, 2012, Pages 3809-3818

  Chang, Shu Jung ^a,b   Shih, Ao Chun ^a,b   Tang, Yin Liang ^a,c   Chang, Wen ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; PROTEIN A16; PROTEIN A26; PROTEIN G9; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; GENE REPRESSION; HUMAN; HUMAN CELL; HYDROPHILICITY; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RESTRICTION SITE; VACCINIA VIRUS; VIRION; VIRUS ENTRY; VIRUS INFECTIVITY;

ENDOCYTOSIS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; PROTEIN BINDING; VACCINIA; VACCINIA VIRUS; VIRAL FUSION PROTEINS; VIRION; VIRUS INTERNALIZATION;

VACCINIA VIRUS;

EID: 84861313720     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06081-11     Document Type: Article

References (63)

1. Armstrong JA, Metz DH, Young MR. 1973. The mode of entry of vaccinia virus into L cells. J. Gen. Virol. 21:533-537.
2. Bengali Z, Townsley AC, Moss B. 2009. Vaccinia virus strain differences in cell attachment and entry. Virology 389:132-140.
3. Bisht H, Weisberg AS, Moss B. 2008. Vaccinia virus l1 protein is required for cell entry and membrane fusion. J. Virol. 82:8687- 8694.
4. Bordier C. 1981. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1604 -1607.
5. Brown E, Senkevich TG, Moss B. 2006. Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein. J. Virol. 80:9455-9464.
6. Carter GC, Law M, Hollinshead M, Smith GL. 2005. Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J. Gen. Virol. 86:1279 -1290.
7. Chang A, Metz DH. 1976. Further investigations on the mode of entry of vaccinia virus into cells. J. Gen. Virol. 32:275-282.
8. Chang SJ, Chang YX, Izmailyan R, Tang YL, Chang W. 2010. Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells. J. Virol. 84:8422- 8432.
9. Chang SJ, et al. 2009. Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-B activation by tumor necrosis factor alpha but is independent of its host range function. J. Virol. 83:4140-4152.
10. Ching YC, et al. 2009. Disulfide bond formation at the C termini of vaccinia virus A26 and A27 proteins does not require viral redox enzymes and suppresses glycosaminoglycan-mediated cell fusion. J. Virol. 83: 6464-6476.
11. Chiu WL, Lin CL, Yang MH, Tzou DL, Chang W. 2007. Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin. J. Virol. 81:2149 -2157.
12. Chung CS, et al. 2006. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J. Virol. 80:2127- 2140.
13. Chung CS, Hsiao JC, Chang YS, Chang W. 1998. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J. Virol. 72: 1577-1585.
14. Condit RC, Moussatche N, Traktman P. 2006. In a nutshell: structure and assembly of the vaccinia virion. Adv. Virus Res. 66:31-124.
15. Dales S, Kajioka R. 1964. The cycle of multiplication of vaccinia virus in Earle's strain L cells. I. Uptake and penetration. Virology 24:278 -294.
16. Dollery SJ, Delboy MG, Nicola AV. 2010. Low pH-induced conformational change in herpes simplex virus glycoprotein B. J. Virol. 84:3759- 3766.
17. Doms RW, Blumenthal R, Moss B. 1990. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J. Virol. 64:4884- 4892.
18. Engelstad M, Smith GL. 1993. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194:627- 637.
19. Gong SC, Lai CF, Esteban M. 1990. Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology 178:81-91.
20. Guan KL, Dixon JE. 1991. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192:262-267.
21. Hsiao JC, Chung CS, Chang W. 1998. Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain. J. Virol. 72:8374-8379.
22. Hsiao JC, Chung CS, Chang W. 1999. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J. Virol. 73:8750-8761.
23. Huang CY, et al. 2008. A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis. J. Virol. 82:7988 -7999.
24. Ichihashi Y, Dales S. 1971. Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Virology 46: 533-543.
25. Ichihashi Y, Oie M. 1983. The activation of vaccinia virus infectivity by the transfer of phosphatidylserine from the plasma membrane. Virology 130:306 -317.
26. Izmailyan RA, Huang CY, Mohammad S, Isaacs SN, Chang W. 2006. The envelope G3L protein is essential for entry of vaccinia virus into host cells. J. Virol. 80:8402- 8410.
27. Kielian M, Helenius A. 1985. pH-induced alterations in the fusogenic spike protein of Semliki Forest virus. J. Cell Biol. 101:2284 -2291.
28. Kohno K, Sambrook J, Gething M-J. 1988. Effect of lysosomotropic agents on the entry of vaccinia virus into CV-1 cells. J. Cell. Biochem. 38(Suppl 12):1.
29. Laliberte JP, Moss B. 2009. Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry. Proc. Natl. Acad. Sci. U. S. A. 106:17517-17521.
30. Law KM, Smith GL. 1992. A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. J. Gen. Virol. 73:549 -557.
31. Law M, Carter GC, Roberts KL, Hollinshead M, Smith GL. 2006. Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc. Natl. Acad. Sci. U. S. A. 103:5989 -5994.
32. Lin CL, Chung CS, Heine HG, Chang W. 2000. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J. Virol. 74:3353-3365.
33. Locker JK, et al. 2000. Entry of the two infectious forms of vaccinia virus at the plasma membrane is signaling-dependent for the IMV but not the EEV. Mol. Biol. Cell 11:2497-2511.
34. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535.
35. Moss B. 2007. Poxviridae: the viruses and their replication, p 2905-2945. In Knipe DM, et al (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
36. Moss B. 2006. Poxvirus entry and membrane fusion. Virology 344:48 -54.
37. Nichols RJ, Stanitsa E, Unger B, Traktman P. 2008. The vaccinia virus gene I2L encodes a membrane protein with an essential role in virion entry. J. Virol. 82:10247-10261.
38. Oie M, Shida H, Ichihashi Y. 1990. The function of the vaccinia hemagglutinin in the proteolytic activation of infectivity. Virology 176:494 -504.
39. Ojeda S, Domi A, Moss B. 2006. Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex. J. Virol. 80:9822-9830.
40. Ojeda S, Senkevich TG, Moss B. 2006. Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene. J. Virol. 80:51- 61.
41. Payne L. 1978. Polypeptide composition of extracellular enveloped vaccinia virus. J. Virol. 27:28 -37.
42. Payne LG, Norrby E. 1978. Adsorption and penetration of enveloped and naked vaccinia virus particles. J. Virol. 27:19 -27.
43. Resch W, Hixson KK, Moore RJ, Lipton MS, Moss B. 2007. Protein composition of the vaccinia virus mature virion. Virology 358:233-247.
44. Satheshkumar PS, Moss B. 2009. Characterization of a newly identified 35-amino-acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses. J. Virol. 83:12822-12832.
45. Seki M, Oie M, Ichihashi Y, Shida H. 1990. Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants. Virology 175:372-384.
46. Senkevich TG, Moss B. 2005. Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion. J. Virol. 79:4744-4754.
47. Senkevich TG, Ojeda S, Townsley A, Nelson GE, Moss B. 2005. Poxvirus multiprotein entry-fusion complex. Proc. Natl. Acad. Sci. U. S. A. 102: 18572-18577.
48. Senkevich TG, Ward BM, Moss B. 2004. Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene. J. Virol. 78:2357-2366.
49. Townsley AC, Moss B. 2007. Two distinct low-pH steps promote entry of vaccinia virus. J. Virol. 81:8613- 8620.
50. Townsley AC, Senkevich TG, Moss B. 2005. The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion. J. Virol. 79:10988 -10998.
51. Townsley AC, Senkevich TG, Moss B. 2005. Vaccinia virus A21 virion membrane protein is required for cell entry and fusion. J. Virol. 79:9458- 9469.
52. Townsley AC, Weisberg AS, Wagenaar TR, Moss B. 2006. Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. J. Virol. 80:8899-8908.
53. Turner PC, et al. 2007. Vaccinia virus temperature-sensitive mutants in the A28 gene produce non-infectious virions that bind to cells but are defective in entry. Virology 366:62-72.
54. Turner PC, Moyer RW. 1995. Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion. J. Virol. 69:5978 -5987.
55. Turner PC, Moyer RW. 1992. An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse. J. Virol. 66:2076 -2085.
56. Turner PC, Moyer RW. 2008. The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus. Virology 380:226 -233.
57. Wagenaar TR, Moss B. 2007. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J. Virol. 81:6286-6293.
58. Wagenaar TR, Moss B. 2009. Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion. J. Virol. 83:1546- 1554.
59. Wagenaar TR, Ojeda S, Moss B. 2008. Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex. J. Virol. 82:5153-5160.
60. Whitbeck JC, Foo CH, Ponce de Leon M, Eisenberg RJ, Cohen GH. 2009. Vaccinia virus exhibits cell-type-dependent entry characteristics. Virology 385:383-391.
61. Wolfe CL, Moss B. 2011. Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex. Virology 412:278 -283.
62. Wolfe CL, Ojeda S, Moss B. 2012. Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex. J. Virol. 86:293- 301.
63. Zhou J, Sun XY, Fernando GJ, Frazer IH. 1992. The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. Virology 189:678-686.